| Micro-channel |
 |
|
|
|
|
|
| |
| In gansu, 40 Chinese medicines are mainly monitored for different kinds of monitoring |
| |
| Author：中国铭铉 企划部 Release Time：2017-9-11 11:28:55 Number Browse：900 |
| |
For the first time in 2017, gansu province released the list of key monitoring varieties for Chinese traditional Chinese medicine. In 2017, the monitoring frequency has been greatly reduced compared to 2016.
▍ variety different monitoring
On September 8, gansu provincial food and drug administration issued a list of key monitoring varieties of traditional Chinese medicine, involving 40 Chinese medicines. Such as alum, valley fine grass, chai hu, sour date kernel, etc.
In 2016, the food and drug administration of gansu released four lists of key monitoring varieties of traditional Chinese medicine. Cypress blue, by looking at the 2016 monitoring list, found that many Chinese medicine tablets appeared on top of the list of key monitors.
Algae, leeches, myrrh, guernwort, sea sands, orange stalks, astragalus, angelica dahurica, kudzu, granule, and bone fragments have been on top of the list for all of 2016.
The frequency of jujube kernel, schisandra, the former hu, the orange, the aloes, the palatine and the white are also between 2 and 3 times.
Raw materials are the main factors that affect the quality of Chinese medicine, while the raw materials of Chinese medicine are influenced by variety, ecological environment and harvest.
Chinese traditional Chinese medicine, such as wu zhuyu, which has been affected by the seasonal solar term, has been shown on the list of key monitoring lists for the whole of 2016.
In order to ensure the quality of medicinal materials, Chinese traditional Chinese medicine families have summarized a series of principles of collection and collection time:
Root and rhizome classes generally at the beginning of autumn and winter solstice spring harvest, stem wood classes generally harvested in the autumn, winter two season, leather generally in the late spring early summer harvest, leafy general before flowers or fruit green before the harvest, when the flowers bud generally or open harvesting, the fruit is in commonly or nearly mature harvest, when the grass stems leafiness recovery and so on.
Glycyrrhizic acid, the main active ingredient in liquorice, is nearly twice as high as one year's growth in 3 ~ 4 years. Alkaloids in grass and ephedra are the highest in August and September, and the lowest in spring. The wormwood is a good harvest, as the saying goes, "in the first month, in the first month, in the spring, in March, the wood will burn." Tianma winter harvest is "winter hemp", spring harvest is "spring hemp", "winter hemp" quality, "spring hemp" quality time; The velvet antler should be sawn from mid-may to late July, and the old bone is the Angle; Gold and silver flowers are picked at 9 a.m. in the morning. The dogwood harvest when the frost turns red; The above examples illustrate the importance of the quality of traditional Chinese medicine.
▍ dual factors call for strong regulation
According to Chinese medicine yinpian, the annual hot word, one side is, nearly 10 years, Chinese medicine yinpian maintain strong growth momentum, sales growth in 2016 is as high as 15%, and about 18% growth expected in 2017, Chinese medicine yinpian, which can realize industrial sales of 230 billion yuan; Side is that the Chinese herbal medicine planting harvest period, processing production, production and marketing storage terminals, market circulation process, formula and drug consumption and so on each link between each other or are not synchronized, Chinese medicine yinpian market chaos, become the worst-hit areas.
Behind these two seemingly contradictory phenomena, the same is the need to strengthen the monitoring of traditional Chinese medicine.
As of October 27, 2015, a total of 100 pharmaceutical companies have been recovered from GMP certificates. Among the 100 pharmaceutical companies that have received GMP certificates, 63 pharmaceutical companies have been pharmaceutical companies, accounting for 63 percent of the pharmaceutical companies.
The most of the provinces are 14 in guangdong, followed by gansu with 12. Seeing this data, it is not difficult to understand the heavy blow to the regulation of traditional Chinese medicine in 2016.
By the way, in 2017, there is a decrease in the monitoring frequency of traditional Chinese medicine in gansu province, or is it a sign that the quality of Chinese traditional Chinese medicine has picked up in the last year?
|
| |
Previous article：The "two-ticket system" is more standard in the field of drug circulation
Next article：These policies will affect doctors nationwide in September
|
| |
|
|
